464 related articles for article (PubMed ID: 18661429)
1. Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications.
Tsochatzis EA; Manolakopoulos S; Papatheodoridis GV; Archimandritis AJ
Scand J Gastroenterol; 2009; 44(1):6-14. PubMed ID: 18661429
[TBL] [Abstract][Full Text] [Related]
2. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
[TBL] [Abstract][Full Text] [Related]
3. Review article: non-alcoholic fatty liver disease and hepatitis C--risk factors and clinical implications.
Sanyal AJ
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():48-51. PubMed ID: 16225473
[TBL] [Abstract][Full Text] [Related]
4. [Non-alcoholic fatty liver disease--new view].
Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; MiezyĆska-Kurtycz J; Milkiewicz P
Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
[TBL] [Abstract][Full Text] [Related]
7. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
Rafiq N; Younossi ZM
Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
[TBL] [Abstract][Full Text] [Related]
8. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease and hepatitis C infection.
Bondini S; Younossi ZM
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response.
Younossi ZM; McCullough AJ
Liver Int; 2009 Mar; 29 Suppl 2():3-12. PubMed ID: 19187068
[TBL] [Abstract][Full Text] [Related]
11. [Non-alcoholic fatty liver].
Tagle Arrospide M
Rev Gastroenterol Peru; 2003; 23(1):49-57. PubMed ID: 12768215
[TBL] [Abstract][Full Text] [Related]
12. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
Tilg H; Moschen A
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of metabolic syndrome in non-diabetic and non-cirrhotic patients with non-alcoholic steatohepatitis.
Amarapurkar DN; Patel ND
Trop Gastroenterol; 2004; 25(3):125-9. PubMed ID: 15682659
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic steatohepatitis and the metabolic syndrome.
Jiang J; Torok N
Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830
[TBL] [Abstract][Full Text] [Related]
15. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
[TBL] [Abstract][Full Text] [Related]
16. [Chronic liver disease and arteriosclerosis].
Mawatari S; Uto H; Tsubouchi H
Nihon Rinsho; 2011 Jan; 69(1):153-7. PubMed ID: 21226276
[TBL] [Abstract][Full Text] [Related]
17. Review article: nonalcoholic fatty liver disease and hepatitis C virus--partners in crime.
Blonsky JJ; Harrison SA
Aliment Pharmacol Ther; 2008 May; 27(10):855-65. PubMed ID: 18315584
[TBL] [Abstract][Full Text] [Related]
18. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
Castera L
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic steatohepatitis and metabolic syndrome.
Machado M; Cortez-Pinto H
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
[TBL] [Abstract][Full Text] [Related]
20. Review article: the metabolic syndrome and non-alcoholic fatty liver disease.
Loria P; Lonardo A; Carulli L; Verrone AM; Ricchi M; Lombardini S; Rudilosso A; Ballestri S; Carulli N
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():31-6. PubMed ID: 16225469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]